This is why they are being suedI had a hard time finding the reason Antibe is being sued by Nuance Pharma.
From Steetwise reports https://www.streetwisereports.com/article/2023/06/30/biotech-co-remains-opportunity-for-those-with-high-risk-tolerance.html
Nuance Pharma is seeking to rescind their license agreement with Antibe Pharmaceuticals due to allegations that Antibe failed to adequately disclose information regarding the risks associated with transaminase elevations linked to otenaproxesul, which is a drug covered by the agreement. Nuance alleges that this lack of disclosure constitutes a breach of the agreement. Despite these claims, analysts believe it's unlikely that Antibe will have to return the upfront payment as the risks of potential side-effects were well-known. Antibe completed an arbitration proceeding with Nuance in May and expects the decision in the future.
In case you're wondering:
Transaminase elevations refer to higher than normal levels of certain enzymes in the blood, specifically alanine transaminase (ALT) and aspartate transaminase (AST). These enzymes are typically found within liver cells, and when the liver is damaged or inflamed, they can leak into the bloodstream, causing elevated levels. So, transaminase elevations often indicate liver damage or liver disease.
We all now know the outcome:
https://markets.ft.com/data/announce/detail?dockey=600-202404010700BIZWIRE_USPRX____20240401_BW046957-1